Susquehanna International Group’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Sell |
32,796
-523,797
| -94% | -$2.04M | ﹤0.01% | 5792 |
|
|
2025
Q1 | $2.11M | Buy |
556,593
+181,748
| +48% | +$689K | ﹤0.01% | 2230 |
|
|
2024
Q4 | $2.04M | Buy |
374,845
+273,395
| +269% | +$1.48M | ﹤0.01% | 1958 |
|
|
2024
Q3 | $425K | Buy |
101,450
+58,077
| +134% | +$243K | ﹤0.01% | 3876 |
|
|
2024
Q2 | $128K | Sell |
43,373
-165,959
| -79% | -$490K | ﹤0.01% | 5004 |
|
|
2024
Q1 | $580K | Buy |
209,332
+181,713
| +658% | +$503K | ﹤0.01% | 3345 |
|
|
2023
Q4 | $78.4K | Buy |
+27,619
| New | +$78.4K | ﹤0.01% | 5426 |
|
|
2023
Q3 | – | Sell |
-16,923
| Closed | -$73.1K | – | 5724 |
|
|
2023
Q2 | $73.1K | Buy |
+16,923
| New | +$73.1K | ﹤0.01% | 5112 |
|
|
2022
Q4 | – | Sell |
-35,258
| Closed | -$44K | – | 6029 |
|
|
2022
Q3 | $44K | Buy |
+35,258
| New | +$44K | ﹤0.01% | 5529 |
|
|
2022
Q2 | – | Sell |
-16,324
| Closed | -$41K | – | 5988 |
|
|
2022
Q1 | $41K | Buy |
16,324
+2,259
| +16% | +$5.67K | ﹤0.01% | 5350 |
|
|
2021
Q4 | $52K | Sell |
14,065
-46,364
| -77% | -$171K | ﹤0.01% | 5454 |
|
|
2021
Q3 | $242K | Buy |
60,429
+13,264
| +28% | +$53.1K | ﹤0.01% | 4512 |
|
|
2021
Q2 | $210K | Buy |
+47,165
| New | +$210K | ﹤0.01% | 4796 |
|